SynthesisMedical oncology (Northwood, London, England)2015

The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis.

Yaxiong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.